Repositorio Dspace

The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia

Mostrar el registro sencillo del ítem

dc.contributor.author Diaz-Beya, M
dc.contributor.author Pratcorona, M
dc.contributor.author Nomdedeu, M
dc.contributor.author Risueno, R-M
dc.contributor.author Brunet, S
dc.contributor.author Nomdedeu, J
dc.contributor.author Hoyos, M
dc.contributor.author Sierra, J
dc.contributor.author Cordeiro, A
dc.contributor.author Castellano, J-J
dc.contributor.author Monzo, M
dc.contributor.author Navarro, A
dc.contributor.author Tormo, M
dc.contributor.author Escoda, L
dc.contributor.author Ribera, J-M
dc.contributor.author Arnan, M
dc.contributor.author Heras-Fernando, Inmaculada
dc.contributor.author Gallardo, D
dc.contributor.author Bargay, J
dc.contributor.author Queipo-de-Llano, M-P
dc.contributor.author Salamero, O
dc.contributor.author Marti, J-M
dc.contributor.author Sampol, A
dc.contributor.author Pedro, C
dc.contributor.author Esteve, J
dc.date.accessioned 2026-10-21T06:12:26Z
dc.date.available 2026-10-21T06:12:26Z
dc.date.issued 2015-10-02
dc.identifier.citation Díaz-Beyá M, Brunet S, Nomdedéu J, Cordeiro A, Tormo M, Escoda L, et al. The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia. Blood Cancer Journal. 2 de octubre de 2015;5(10):e352-e352. doi:10.1038/bcj.2015.76
dc.identifier.issn 2044-5385
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/28760
dc.description.abstract Acute myeloid leukemia (AML) is a heterogeneous disease whose prognosis is mainly related to the biological risk conferred by cytogenetics and molecular profiling. In elderly patients (?60 years) with normal karyotype AML miR-3151 have been identified as a prognostic factor. However, miR-3151 prognostic value has not been examined in younger AML patients. In the present work, we have studied miR-3151 alone and in combination with BAALC, its host gene, in a cohort of 181 younger intermediate-risk AML (IR-AML) patients. Patients with higher expression of miR-3151 had shorter overall survival (P=0.0025), shorter leukemia-free survival (P=0.026) and higher cumulative incidence of relapse (P=0.082). Moreover, in the multivariate analysis miR-3151 emerged as independent prognostic marker in both the overall series and within the unfavorable molecular prognostic category. Interestingly, the combined determination of both miR-3151 and BAALC improved this prognostic stratification, with patients with low levels of both parameters showing a better outcome compared with those patients harboring increased levels of one or both markers (P=0.003). In addition, we studied the microRNA expression profile associated with miR-3151 identifying a six-microRNA signature. In conclusion, the analysis of miR-3151 and BAALC expression may well contribute to an improved prognostic stratification of younger patients with IR-AML.
dc.language.iso eng
dc.rights Atribución/Reconocimiento 4.0 Internacional
dc.rights.uri https://creativecommons.org/licenses/by/4.0/deed.es *
dc.subject.mesh Adolescent
dc.subject.mesh Adult
dc.subject.mesh Aged
dc.subject.mesh Biomarkers, Tumor/genetics
dc.subject.mesh Cytogenetic Analysis
dc.subject.mesh Disease-Free Survival
dc.subject.mesh Female
dc.subject.mesh Humans
dc.subject.mesh Kaplan-Meier Estimate
dc.subject.mesh Leukemia, Myeloid, Acute/genetics/mortality
dc.subject.mesh Male
dc.subject.mesh MicroRNAs/genetics
dc.subject.mesh Middle Aged
dc.subject.mesh Neoplasm Proteins/genetics
dc.subject.mesh Prognosis
dc.subject.mesh Proportional Hazards Models
dc.subject.mesh Risk Factors
dc.subject.mesh Transcriptome
dc.subject.mesh Young Adult
dc.title The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia
dc.type info:eu-repo/semantics/article 
dc.identifier.pmid 26430723
dc.relation.publisherversion https://www.nature.com/articles/bcj201576
dc.type.version info:eu-repo/semantics/publishedVersion
dc.identifier.doi 10.1038/bcj.2015.76
dc.journal.title Blood Cancer Journal


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento 4.0 Internacional Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento 4.0 Internacional

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta